A randomised control trial investigating the effect of temazepam on sleep in critically ill patients
Phase 4
Completed
- Conditions
- Sleep disruptionNeurological - Other neurological disorders
- Registration Number
- ACTRN12621000742875
- Lead Sponsor
- Melbourne Health
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 56
Inclusion Criteria
•Aged >/= 18 years
•The treating clinician considers it highly likely that they would prescribe a pharmacological sleep aid that evening
Exclusion Criteria
•The treating clinician believes that an alternative sedating drug (e.g. quetiapine, melatonin, etc.) is in the best interest of the patient,
•They are pregnant,
•They have a known hypersensitivity to temazepam, and
•Were previously enrolled in this trial.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Total sleep duration, in minutes, as measured by the bedside nurse. [ The 12 hours following the intervention or control administration.]
- Secondary Outcome Measures
Name Time Method